Inventor · disambiguated record
Bart De Goeij
Also filed as: DE GOEIJ BART · DE GOEIJ BART E C G
16 granted patents·23 pending applications·221 citations·filing 2011–2024
93Inventor score
Top patents by PatentIndex Score
39 records- 0197US11866514B2Heterodimeric antibody Fc-containing proteins and methods for production thereofGENMAB AS·Filed 2020·Granted Jan 9, 2024·5 cites·37 claims
- 0297US10597464B2Heterodimeric antibody Fc-containing proteins and methods for production thereofGENMAB AS·Filed 2017·Granted Mar 24, 2020·35 cites·12 claims
- 0397US9150663B2Heterodimeric antibody Fc-containing proteins and methods for production thereofLABRIJN ARAN FRANK·Filed 2011·Granted Oct 6, 2015·119 cites·37 claims
- 0492US9657107B2Monoclonal antibodies against c-MetGENMAB AS·Filed 2015·Granted May 23, 2017·9 cites·25 claims
- 0591US11008399B2AntibodiesGENMAB AS·Filed 2020·Granted May 18, 2021·2 cites·22 claims
- 0690US9862769B2Monoclonal antibodies against HER2DE GOEIJ BART·Filed 2011·Granted Jan 9, 2018·16 cites·42 claims
- 0790US9714294B2Monoclonal antibodies against HER2 epitopeDE GOEIJ BART·Filed 2011·Granted Jul 25, 2017·17 cites·43 claims
- 0888US11130819B2AntibodiesGENMAB AS·Filed 2021·Granted Sep 28, 2021·1 cites·30 claims
- 0988US9068011B2Monoclonal antibodies against c-MetNEIJSSEN JOOST J·Filed 2011·Granted Jun 30, 2015·12 cites·24 claims
- 1086US2024209117A1Heterodimeric antibody fc-containing proteins and methods for production thereofGENMAB AS·Filed 2023·Application pending·0 cites
- 1185US11046771B2Monoclonal antibodies against HER2GENMAB AS·Filed 2017·Granted Jun 29, 2021·2 cites·23 claims
- 1285US2024392032A1AntibodiesGENMAB AS·Filed 2024·Application pending·0 cites
- 1384US2024084036A1Monoclonal antibodies against c-metGENMAB AS·Filed 2022·Application pending·0 cites
- 1481US11578141B2Bispecific antibodies against HER2 and CD3GENMAB AS·Filed 2019·Granted Feb 14, 2023·1 cites·11 claims
- 1580US11091553B2Monoclonal antibodies against HER2GENMAB AS·Filed 2017·Granted Aug 17, 2021·1 cites·20 claims
- 1680US2025066506A1Bispecific antibodies against her2GENMAB AS·Filed 2024·Application pending·0 cites
- 1779US10793640B2Monoclonal antibodies against HER2 epitopeGENMAB AS·Filed 2017·Granted Oct 6, 2020·1 cites·38 claims
- 1877US2024317881A1Variants of cd38 antibody and uses thereofGENMAB AS·Filed 2024·Application pending·0 cites
- 1976US11970544B2AntibodiesGENMAB AS·Filed 2021·Granted Apr 30, 2024·0 cites·31 claims
- 2076US11512140B2Monoclonal antibodies against c-MetGENMAB AS·Filed 2019·Granted Nov 29, 2022·0 cites·27 claims
- 2175US12351650B2Antibodies binding to fibroblast activation protein alpha and death receptor 4GENMAB AS·Filed 2024·Granted Jul 8, 2025·0 cites·34 claims
- 2274US2024317861A1Antibodies against pd-l1GENMAB AS·Filed 2023·Application pending·0 cites
- 2373US2022169738A1Monoclonal antibodies against her2GENMAB AS·Filed 2021·Application pending·0 cites
- 2468US2020277397A1AntibodiesGENMAB AS·Filed 2020·Application pending·0 cites
- 2567US2021324105A1Bispecific antibodies against her2GENMAB AS·Filed 2021·Application pending·0 cites
- 2666US2023076417A1Multispecific antigen-binding molecule with improved internalization characteristicsGENMAB AS·Filed 2022·Application pending·0 cites
- 2765US2021122830A1Monoclonal antibodies against her2 epitopeGENMAB AS·Filed 2020·Application pending·0 cites
- 2862US2017313782A1Monoclonal antibodies against c-metGENMAB AS·Filed 2017·Application pending·0 cites
- 2962US2017320962A1Monoclonal antibodies against c-metGENMAB AS·Filed 2017·Application pending·0 cites
- 3055US2016046727A1Heterodimeric antibody fc-containing proteins and methods for production thereofGENMAB AS·Filed 2015·Application pending·0 cites
- 3153US2020239579A1Antibodies against pd-l1GENMAB AS·Filed 2018·Application pending·0 cites
- 3253US2017369590A1Bispecific antibodies against her2GENMAB AS·Filed 2017·Application pending·0 cites
- 3353US2017369594A1Bispecific antibodies against her2 and cd3GENMAB AS·Filed 2017·Application pending·0 cites
- 3450US2014170149A1Bispecific antibodies against her2 and cd3NEIJSSEN JOOST J·Filed 2012·Application pending·0 cites
- 3550US2023257479A1Bispecific antibodies binding to 5t4 and cd3 for use in treatment of cancerGENMAB AS·Filed 2020·Application pending·0 cites
- 3648US2021308208A1Anti-tissue factor antibody-drug conjugates and their use in the treatment of cancerGENMAB AS·Filed 2019·Application pending·0 cites
- 3747US2019352423A1Multispecific antigen-binding molecule with improved internalization characteristicsGENMAB AS·Filed 2017·Application pending·0 cites
- 3846US2024254252A1Trogocytosis-mediated therapy using cd38 antibodiesGENMAB AS·Filed 2019·Application pending·0 cites
- 3941US2014170148A1Bispecific antibodies against her2DE GOEIJ BART·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bart De Goeij files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →